Epidermal keratinocytes and hair follicle (HF) stem cells (SCs) expressing oncogenes are competent at developing squamous cell carcinomas (SCCs) in epidermis and HFs, respectively. To determine whether bulge and hair germ (HG) SCs from HF contribute to SCC generation at distant epidermis, the most frequent epidermal region where these lesions arise in human skin, we used a skin cancer mouse model expressing E6 and E7 oncoproteins from Human papillomavirus (HPV) 16 in SCs and basal keratinocytes. This previously described mouse model recapitulates the human skin papillomavirus-induced SCC pathology. We show that E6 and E7 expression promote the expansion of keratin 15 (K15)-expressing cells. These K15 þ aberrant cells exhibit some HGSC markers and diminished expression of Tcf3 and Sox9 hair SC specification genes, which are accumulated in HFs and mislocalized to interfollicular epidermis. Leucine-rich G-protein-coupled receptor 5 (Lgr5)-expressing SCs, localized in the bulge and HG, are the origin of the expanded K15 þ cell population. A large subset of the Lgr5 þ SC progeny, expressing K15 and P-cadherin, is aberrantly mobilized to the upper region of HFs and the epidermis, and accumulates at E6/E7-induced pre-neoplastic lesions and epidermal tumors. These findings indicate that aberrant accumulation of altered SCs in HFs and their subsequent migration to the epidermis contribute to HPV-induced tumor development.
INTRODUCTION
The epidermis encompasses the interfollicular epidermis (IFE) and associated appendages, such as hair follicles (HFs) and sebaceous glands. In adult mouse skin, the IFE and sebaceous glands undergo constant renewal, whereas HFs cycle between phases of growth (anagen), involution (catagen) and resting (telogen), enabling hair regeneration. 1 Resting HFs contain a lower region, comprising the bulge and the secondary hair germ (HG), and an upper region, formed by the isthmus and the infundibulum, which interfaces with the IFE. These HF regions and the sebaceous glands are thought to be maintained by its own population of stem cells (SCs). 2 However, the functional relationship between these SC populations is complex, and bulge SCs may contribute to the maintenance of sebaceous glands. 3 Bulge SCs are characterized by the expression of a6-integrin, along with CD34, cytokeratin 15 (K15), Sox9, Tcf3 and Lhx2 among other markers. [4] [5] [6] [7] [8] Leucine-rich G-protein-coupled receptor 5 (Lgr5) identifies a subset of cells localized at the bottom of the bulge. 9 HGSCs generated from bulge SCs 10 are characterized by the expression of basal a6-integrin, K15, Lgr5, Lhx2 and P-cadherin and the loss of CD34 expression. 11, 12 Lineage-tracing experiments demonstrated that these HF SC populations are involved in the homeostasis of HFs, but not in that of the IFE in mice. Nevertheless, after injury, HF SCs can migrate upwards to repair epidermal damage. 13 The most common human epithelial skin cancers are basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs), the latter being more aggressive and prone to metastasis.
14 Human papillomavirus (HPV) infection is involved in the etiology of epidermal SCCs, the high-risk b-type HPVs (such as HPV5 and HPV8) being more related to skin SCC development, in close association with sun exposure and immunodeficiency. [15] [16] [17] High-risk a-type HPVs (HPV16 and HPV18) are involved in SCC development in anogenital and head and neck areas. 17, 18 However, HPV16 was also detected in human skin SCCs, indicating that this HPV type is competent at inducing malignant skin lesions. 19, 20 HPV16 encodes oncoproteins E6 and E7, which inactivate several proteins, the retinoblastoma (Rb) protein family and the tumor-suppressor protein p53 being the best characterized of these. 21 The impact of HPV16 E6 and E7 expression on skin cancer was demonstrated through the generation of the K14-HPV16 mouse model. 22 HPV16 E6 and E7 expression in these mice is driven by the K14 promoter to basal keratinocytes, including HF SCs. These mice develop spontaneous SCCs that frequently start off as hyperplasias and dysplasias in the IFE, 23 recapitulating HPV-induced pathology in human skin. 24 Although this carcinogenesis mouse model is well characterized, cells that actually contribute to E6/E7-induced skin tumors are still unknown.
Epidermal keratinocytes and HF SCs are competent at originating skin SCCs. Indeed, conditional expression of the constitutively active KRas G12D and abrogation of the p53 function in IFE keratinocytes and bulge SCs and their immediate progeny promote generation of SCCs in IFE and HFs, respectively. 25, 26 However, it is not known whether mutated SCs, localized in the HFs, can contribute to neoplastic lesions that usually develop in the IFE, and which are the mechanisms involved in this process. In this regard, the cell target of HPV infection are the basal keratinocytes, including HF SCs, and HFs are a natural reservoir of HPV. 27 Here we determine the impact of E6 and E7 expression on the homeostasis and dynamics of HF SCs during SCC development, and address the involvement of these SCs in HPV16-induced skin tumorigenesis at the IFE.
RESULTS

E6 and E7 expression induces aberrant accumulation and mislocalization of K15
þ -expressing cells K14-HPV16/K15-enhanced green fluorescent protein (EGFP) mice, generated by crossing K14-HPV16 Tg/ þ and K15-EGFP Tg/Tg mice, were used to evaluate the impact of E6 and E7 expression on HF SC homeostasis. They developed hyperplasias and dysplasias early at the IFE and spontaneous SCCs (32% of mice) by age 1 year, recapitulating the phenotype previously reported in K14-HPV16 Tg/ þ mice. 23 EGFP expression under K15 promoter enables identification of bulge SCs and HGSCs during tumorigenesis. 6 We quantified the percentage of a6-integrin þ /K15-EGFP high SCs in WT/K15-EGFP Tg/ þ (WT-K15) and K14-HPV16 Tg/ þ /K15-EGFP Tg/ þ (E6/E7-K15) mouse skins. The a6-integrin þ /K15-EGFP high cell population was significantly larger in all E6/E7-K15 skins, regardless of mouse age (Figures 1a and b) . Stronger expression of K15 and EGFP in the E6/E7-K15 skins was corroborated by western blot (Supplementary Figure S1a) . In WT-K15 skins, the majority of K15-EGFP þ cells were localized in the lower region of HFs (bulge and HG); only a small subset was occasionally found in the upper region of HFs and in the IFE (Figure 1c; Supplementary Figures S1c  and d) , as previously reported. 6, 26 However, in E6/E7-K15 mice, the population of K15 þ cells was significantly larger in the bulge and HG, and a subset of K15 þ cells was mislocalized in the upper region of HFs and in the IFE in the absence of pre-neoplastic lesions (Figure 1c, Supplementary Figures S1b-d Figure S2b) . Interestingly, E6/E7-K15 mice older than 16 weeks accumulated K15-expressing cells in hyperplastic and dysplastic regions of the IFE (Figures 1d and e) , suggesting that these aberrant cells may be involved in pre-neoplastic lesion development.
The analysis of the expression of HF SC markers in a6-integrin þ /CD34 þ and a6-integrin þ /CD34 À /K15-EGFP high cells isolated from WT-K15 skins indicated that, as expected, these cells upregulated the expression of bulge SC and HGSC markers, whereas a6-integrin þ /CD34 À /K15-EGFP À cells showed strong downregulation of these markers and high levels of expression of Lrg6 and Lrig1, two markers of SC residing in the isthmus and infundibulum (Supplementary Figure S3a) . 28, 29 Figure S3b) , K15
þ -expanded cells display a specific induced gene-expression pattern compared with those of other isolated cell populations (Figure 2a ). These observations rule out the possibility that E6/E7 expression directly induces the expression of these HGSC markers.
In accordance with the expansion of cells exhibiting HGSC markers, E6/E7-K15 skins had a significantly higher percentage of a6-integrin þ /P-cadherin þ cells (Supplementary Figures S4a  and b) , most of which expressed K15-EGFP (Figure 2b ). Stronger expression of P-cadherin in the E6/E7 mouse skins was Lgr5-SC progeny contributes to epidermal SCC V da Silva-Diz et al corroborated by western blot (Supplementary Figure S4c) . As previously reported, 12 most of the cells expressing high levels of P-cadherin were localized in the HG (Figure 2c ) in WT-K15 skins. Nevertheless, the E6/E7 skins had significantly more P-cadherin þ cells in the lower and upper regions of the HF and in the IFE (Figure 2c ). K15-EGFP expression was detected in these expanded and mislocalized P-cadherin þ cells (Figures 2d-f) , which accumulated in hyperplastic regions (Supplementary Figures S4d and e) .
WT-K15
SG
Because Lgr5 identifies bulge SCs and HGSCs, 9 we crossed K14-HPV16 mice with Lgr5-EGFP-Ires-CreER T2 mice, then quantified the
Tg/ þ /Lgr5-EGFP-Ires-CreER T2 (E6/E7-Lgr5) skins. We detected no major differences in the percentage of Lgr5 þ -SCs, which reside in the bulge (a6-integrin Finally, to determine whether E6 and E7 expression can alter the CD34 þ -bulge SC population, we quantified the a6-integrin þ / CD34 þ cell population in WT-K15 and E6/E7-K15 mice. Similar percentages of CD34 þ -bulge SCs and an unaltered localization of these cells at the bulge were observed in WT and E6/E7-K15 mice (Figures 3c and d) . Collectively, our results indicate that E6 and E7 expression leads to the generation of an aberrant cell population that conserves the expression of certain HGSC markers, without modifying the size or location of bulge SCs.
E6/E7 skins show a normal hair cycle despite the activation of bulge SC proliferation and the accumulation of K15 þ / P-cadherin þ -aberrant cells in HFs
To determine which events lead to the accumulation of K15 þ / P-cadherin þ cells, we analyzed the effect of E6 and E7 expression on keratinocyte proliferation. IFE of E6/E7-K15 mice had a significantly higher percentage of Ki67 þ -proliferating keratinocytes (Supplementary Figure S5a) , as previously described. 23 Figure S5a) , and specifically in the population of CD34 þ and K15 þ cells (Figure 3e ; Supplementary Figure S5b ). Furthermore, cell-cycle analysis of CD34 þ -bulge SCs,
À showed that all these cell populations had a significantly higher percentage of S-phase cells in E6/E7-K15 skins (Figure 3f; Supplementary Figure S5c) . Similarly, the Lgr5 þ -SCs from the HG (a6-integrin þ /CD34 À /Lgr5-EGFP þ ) actively proliferated in the E6/E7 mouse skins (Figure 3g ; Supplementary Figure  S5c ). These findings demonstrate that CD34 þ -bulge SCs and Lgr5 þ -SCs divide more actively during the resting phase of the hair cycle in E6/E7 mice than in WT mice, although the size of these cell populations was unaltered.
As upregulation of the Wnt/b-catenin pathway promotes proliferation of bulge SCs and HGSCs at the onset of the hair cycle, 12, 30 we examined whether this pathway was activated under E6/E7 expression. Unlike the WT-K15 controls, which displayed normal b-catenin localization at cell-cell contacts, aberrant nuclear localization of b-catenin was observed in the lower region of telogen HFs in E6/E7 skins (Figure 4a ). In addition, the expression of Tcf3, a cofactor of b-catenin, and of Lgr5 and Axin2, two b-catenin target genes, 31, 32 was significantly stronger in the a6-integrin þ /CD34 þ cells from 8-week-old E6/E7 mice (Figure 4b ), indicating that the b-catenin signaling pathway was upregulated in CD34 þ -bulge SCs. Conversely, we did not observe a higher level of Axin2 expression or even a significantly lower expression of Lgr5, Tcf3 and Lef1 in a6-integrin þ /CD34 À /K15-EGFP high cells, and no altered expression of Lgr5, Lef1 and Tcf3 was detected in basal keratinocytes depleted in bulge SCs and HGSCs in E6/E7-K15 mice (Figure 4b) . Indeed, the loss of Lgr5 expression in these expanded cells was correlated with the absence of size change in the Lgr5 þ -SC population in E6/E7 mice. Furthermore, similar to what was observed in WT-K15 skins, no nuclear b-catenin was detected in IFE keratinocytes of E6/E7-K15 mice (data not shown). Given that a significant population of keratinocytes exhibited K15 expression in the IFE, these results suggest that Wnt/b-catenin signaling is not activated in the mislocalized K15 þ cells and that the aberrant population of K15 þ cells actively proliferates in the absence of activated b-catenin signaling.
Although the CD34 þ -bulge SCs actively proliferated and exhibited upregulated b-catenin signaling, we found no major alterations in the hair coat or hair cycle in E6/E7-K15 mice. Indeed, the skins of mice older than 16 weeks, which presented asynchronous hair cycles, had a similar ratio of anagen follicles to that of WT-K15 mice (Supplementary Figure S6a) . Precocious entry to the anagen phase was not observed during the first telogen phase (21-day-old E6/E7 mice) (Figure 4c ). Furthermore, no altered distribution of K15 þ or P-cadherin þ cells in downward-growing HFs was observed during the first anagen phase in 28-day-old E6/E7-K15 mice (Supplementary Figures S6b and c) . Consistent with normal progression of the hair cycle, no significant changes of hair-specification genes expressed in HF-transient amplifying and matrix cells 12 were observed in E6/E7-K15 skins in anagen (Figure 4d ). These results indicate that a more robust activation of Wnt/b-catenin signaling in bulge SCs and/or other signals orchestrated by dermal fibroblast may be necessary to induce unprogrammed anagen onset in E6/E7 mice. Furthermore, our data suggest that K15 þ cells accumulated in the lower HF did not alter the normal progression of the hair cycle, probably because they are subsequently mobilized to the IFE. (Figure 5a ). Furthermore, although LacZ þ cells were restricted to bulge and HG in the WT skins, the E6/E7 skins also presented LacZ þ cells in the infundibulum and in the IFE, even though the Lgr5 promoter was only active in the bulge and HG in E6/E7-Lgr5-LacZ mice (Figure 5b; Supplementary Figure S7a) . 9 It is important to note that LacZ þ cells in the infundibulum were always observed in those HFs exhibiting LacZ þ cells in their bulge and HG. Likewise, the IFE regions containing LacZ þ cells were close to LacZ þ HFs (Supplementary Figure S7b) . These results indicate that the mislocalized LacZ þ cells are the progeny of Lgr5 þ -SCs of neighbor HFs that are mobilized to the infundibulum and the IFE. As expected, a subset of K15 þ and P-cadherin þ cells expressed b-galactosidase in the bulge and HG (Figure 5c ). Because the low dose of tamoxifen used enabled only a small percentage of Lgr5 þ cells in each HF to be traced, not all the K15 þ and P-cadherin þ cells showed LacZ þ staining. More importantly, our results showed that the LacZ þ cells mobilized at the IFE expressed K15 and P-cadherin proteins (Figure 5c ), indicating that actively proliferating Lgr5 þ -SCs in HFs were the origin of the expanded and mislocalized K15 þ /P-cadherin þ cells at the IFE.
Mobilized Lgr5 þ -SC progeny contributes to development of E6/E7-induced SCCs in the IFE To assess whether mobilized K15 þ cells are involved in tumor development, we first analyzed the presence of K15-EGFP þ in spontaneous and DMBA (7,12-dimethylbenz-alpha-anthracene)-TPA (12-O-tetradecanoyl-phorbol-13-acetate)-induced tumors in E6/E7 mice by flow cytometry. Consistent with previous results, 33 we observed a population of CD34-expressing cells in tumors Lgr5-SC progeny contributes to epidermal SCC V da Silva-Diz et al (Supplementary Table S1 ). We also found a variable percentage of tumor cells expressing K15-EGFP (0.1-58%) that were more abundant in in situ SCCs than in infiltrating SCCs (Figure 6a ; Supplementary Table S1 ). Furthermore, K15 þ and P-cadherin þ cells were detected in SCCs and a subset of tumor cells coexpressed both markers (Figures 6b-d) .
To determine whether the mobilized cells are the origin of epidermal tumors, E6/E7-Lgr5-LacZ mice were treated with tamoxifen during the first telogen phase. Eight-week-old mice were treated with DMBA-TPA and then analyzed for the presence of LacZ þ cells in pre-neoplastic and neoplastic lesions. In accordance with the clonal labeling of Lgr5 þ cells in bulge and HG, groups of LacZ þ cells, clearly delimited by surrounding areas of unlabeled cells, were apparent in most hyperplastic and dysplastic lesions (Figure 7a ). In situ SCCs, an early neoplastic lesion emerging from the IFE, exhibited LacZ þ cells, and 39% of SCCs developed in the E6/E7-Lgr5-LacZ mice were formed by LacZ þ tumor cells (Figure 7a ). Tumors frequently presented a heterogeneous composition of LacZ þ and LacZ À cells, indicating the polyclonal origin of these tumors, as recently suggested. 34 We also found a subset of LacZ þ cells expressing K15 and P-cadherin, and K15-EGFP þ and P-cadherin þ cells were also seen in LacZ À tumor cells (Figure 7b) 
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Relative levels of mRNA Lgr5-SC progeny contributes to epidermal SCC V da Silva-Diz et al from deregulated Lgr5 þ -SC progeny, contribute to the development of E6/E7-induced SCCs in the IFE. DISCUSSION E6 and E7 oncoproteins from HPV are involved in human and mouse skin SCC development, 17, 19, 20, 22 but the cellular origin of these HPV-induced tumors remains unknown. Here we show that E6 and E7 expression induces alterations in HF SC homeostasis and dynamics and that both events contribute to SCC development in the IFE.
Conditional expression of an activated KRas mutant and loss of p53 function, specifically in bulge SCs and their immediate progeny and epidermal keratinocytes, induce SCC generation, indicating that these mutated cells are competent at developing SCCs at the HFs and IFE, respectively. 25, 26 An intriguing question is whether altered SCs, localized in lower regions of the HFs, contribute to neoplastic lesion development in the distant regions of the epidermis. In K14-HPV16 mice, E6 and E7 expression is targeted to epidermal basal keratinocytes and SCs in HFs, and almost all SCCs developed are initiated in the IFE. E6 and E7 expression induces the generation of an aberrant K15-expressing cell population that accumulates in HFs. Lineage-tracing assays showed that the expanded population originates from proliferating Lgr5 þ -SCs in HFs. Indeed, Lgr5 þ -SCs progeny, initially accumulates in the lower HFs, coinciding with the expansion of K15 þ /P-cadherin þ cells at this location, and a subset of them is mobilized to the IFE in E6/E7 mice (Figure 7c ). indicate that the aberrant cell population is not produced in this way: (i) although E6 expression levels were similar in expanded K15-EGFP þ cells and basal keratinocytes depleted in bulge SCs and HGSCs (a6 þ /CD34 À /K15-EGFP -cells), the expression of reported markers was induced only in the former population and these populations had different gene-expression profiles and (ii) the expression of K15 and P-cadherin was observed in some, but not all, K14 þ basal cells in HF and IFE. This study cannot rule out the possibility that some proliferating cells, residing in the infundibulum and the IFE, reacquire expression of HF SC markers, as previously suggested in basal cell carcinoma mouse models. 35, 36 However, the migration of Lgr5 þ -SC progeny to the infundibulum and IFE suggests that a population of these aberrant K15 þ /P-cadherin þ cells, generated in HFs, is mobilized to the IFE. The expanded K15 þ cell population is probably generated by disrupting the balance between SC self-renewal and differentiation of their progeny. Although HFs from E6/E7 mice exhibit similar amounts of CD34 þ bulge SCs and Lgr5 þ SCs as control mice, these cells abnormally divide during the HF resting phase. p53 and Rb control self-renewal in adult SCs from different tissues, including epidermis. [37] [38] [39] [40] In this regard, the absence of pRb is by itself sufficient to promote increased proliferation of bulge SCs, 40 although it is insufficient to promote tumor development. 41 However, the simultaneous abrogation of p53 and Rb in K14-expressing epidermal cells induces spontaneous SCCs. 42 Furthermore, these tumors displayed an increased K15 þ cell population at the early stages, 42 recapitulating some of the E6/E7-induced alterations described here.
Our results show that E6 and E7 expression induces activation of the b-catenin signaling in CD34 þ -SCs, an essential pathway for subsequent production of transient amplified cells during the hair cycle. 30 Although bulge SCs actively proliferated and b-catenin signaling was activated, we did not find any alterations of the hair cycle in E6/E7 skins. These data indicate that the increased Wnt/b-catenin signaling in CD34 þ -bulge SCs was insufficient to interfere with the normal progression of the hair cycle. In this regard, the presence of sustained elevated levels b-catenin in HF SCs, induced by the ectopic expression b-catenin mutant, promoted the activation of bulge SC proliferation and a precocious entry in anagen phase at one defined stage of the hair cycle. 30 This indicates that other factors, in conjunction with Wnt/b-catenin signaling activation, are required to induce hair regeneration. 30 Furthermore, K15-expanded and mobilized cells showed downregulated b-catenin signaling, indicating that these cells proliferate independently of Wnt/b-catenin signaling. Previous studies reported the physiological relevance of Wnt signaling in HF SC homeostasis and lineage determination. Indeed, the abrogation of b-catenin affects HF development and SCs fail to differentiate into follicular keratinocytes, adopting an epidermal fate instead. 43 In addition, Tcf3 and Sox9, expressed in bulge and HG, are important during early HF SC specification. Deletion of these genes impairs the maintenance of bulge SCs and HF development. 4, 8, 44, 45 We observed that accumulated K15 þ cells do not interfere with the normal progression of the hair cycle, probably because they are subsequently mobilized to the IFE. Furthermore, no aberrant nuclear b-catenin was observed in IFE 
À / K15 þ cells. These observations indicate that mobilized K15 þ cells might feature deregulated b-catenin signaling and hairspecification program, favoring the acquisition of IFE features and precluding the formation of ectopic HFs in the IFE.
In the IFE, K15 þ cells actively proliferate at a similar ratio to neighbor K15
À basal keratinocytes, indicating that both populations of cells are competent at developing SCC at this location. Accordingly, lineage-tracing assays demonstrated that mobilized Lgr5 þ -SC progeny, expressing K15 and P-cadherin, initially accumulate in hyperplastic and dysplastic lesions in the IFE, and participate in generating SCCs in this region. In cervix SCCs, the consistent expression of E6 and E7 from HPV16 is necessary not only for tumor initiation but also for malignant tumor progression through the induction of genomic instability among other mechanisms. 46 Therefore, aberrantly mobilized cells, which constantly express E6 and E7, might acquire enough chromosomal instability and mutations at the tumor initiation stage, and thereby participate in SCC development. Interestingly, we observed a higher percentage of K15 þ cells in early neoplastic lesions (in situ SCCs) than in infiltrating SCCs, suggesting that during tumor progression, the expression of this bulge and HG SC marker is lost in some tumor cells by an unknown mechanism. Accordingly, phenotypic features of cells with SC features (such as the expression of some cancer SC markers) may change during tumor growth. 47, 48 The migration of K15 þ cells reported here resembles to that described for the mobilization of HF SCs to epidermal wounds during the initial steps of healing. 13 It is worth noting that wound induction promotes tumor development in injured areas of the IFE 36, 49 and the generation of HPV8-induced SCCs in skin is accelerated by wound induction. Although mobilization of K15 þ /P-cadherin þ cells to the IFE was not associated with any detectable wounds, it may have been analogously promoted by accumulated DNA damage resulting from the absence of p53 function, or in response to other altered signals emerging from E6/E7-expressing IFE keratinocytes, possibly creating a wound-like microenvironment at this location. In addition, HPV16 E6 targets and deregulates the function of several members of the membrane-associated family scaffold proteins (MAGI1-3) and proteins, such as Dlg, Scribble and MUPP1, which, through PDZ-domain interaction, form multiprotein complexes that are involved in cell-to-cell contact via tight junctions, cell polarity and signaling. 50 As a consequence, E6 interaction with PDZ-domain proteins may induce cell motility and activate the signaling pathways involved in survival and proliferation, promoting pre-neoplastic lesions and SCC development. 17, 46 Finally, the strong inflammatory response described in E6/E7 mice 51 could induce the proliferation of HF SCs and their subsequent migration to these areas, contributing to tumorigenesis.
Together, our findings indicate that E6 and E7 expression induces proliferation of bulge SCs and an imbalance in the homeostasis of HF SCs, leading to the expansion and migration of Lgr5 þ -SC progeny to the infundibulum and the IFE, where these aberrant cells contribute to tumor development. The effect of E6 and E7 expression on SC homeostasis described here may provide insight into the mechanism involved in the HPV-induced tumorigenesis in other tissues. The cervical epithelium is the most frequent target tissue of HPV16, and infection with this highrisk HPV is the cause of most cervical SCCs. 18 Interestingly, abnormal activation of Wnt/b-catenin signaling has been reported in HPV-induced cervical and oropharyngeal SCCs, 52, 53 which accelerate the development of tumors. 54 Therefore, although HFs are absent from this epithelium, E6 and E7 expression may induce alterations in the pathways that control cervical SC homeostasis and dynamics, as reported here, leading to the aberrant expansion of this population of cells and promoting tumorigenesis.
MATERIALS AND METHODS
Animal models
To generate the mouse lines described in this study, we used the following mice: K14-HPV16 Tg/ þ , 22 K15-EGFP Tg/Tg 6 and Lgr5-EGFP-Ires-CreER T2 / Rosa26-LacZ. 9 Animal housing and handling, and all procedures involving mice, were approved by the Bellvitge Biomedical Research Institute (IDIBELL) ethics committee, in accordance with Spanish national guidelines and regulations.
Isolation of cells from skin and SCCs
Adult keratinocytes were isolated as described previously. 55 Excised tumors were minced and incubated with collagenase I (60 U/ml; Sigma, St Louis, MO, USA) and dispase (0.7 U/ml; Gibco, Auckland, New Zealand) overnight at 37 1C. 
Flow cytometry
Isolated keratinocytes and tumor cells (100 000 cells per 100 ml buffer, 5% FBS in phosphate-buffered saline) were stained with biotin-labeled CD34 antibody (1:50; eBioscience, San Diego, CA, USA) for 30 min at 4 1C, then with streptavidin-allophycocyanin (1:50; BD Bioscience) and phycoerythrinlabeled a6-integrin (CD49f) antibody (1:50; BD Bioscience) for 30 min at 4 1C. For P-cadherin staining, keratinocytes were incubated with P-cadherin antibody (1 mg/ml; R&D Systems, Minneapolis, MN, USA), biotin-labeled anti-goat antibody (1:300; Dako, Glostrup, Denmark) and then with streptavidin-allophycocyanin (1:50; BD Bioscience). The live cells excluded propidium iodide (Sigma). Fluorescence-activated cell sorting was performed with a BD Bioscience Aria apparatus. To determine the ratio of cells at each cell-cycle phase, sorted populations were fixed in 70% ethanol at À 20 1C, then treated with a solution containing 20 mg/ml propidium iodide (Molecular Probes, Eugene, OR, USA), 0.1% Triton X-100 and 0.2 mg/ml RNAse (Sigma) for 15 min at 37 1C and analyzed by flow cytometry.
Lineage-tracing assays
To activate Cre recombinase in Lgr5-EGFP-Ires-CreER T2 /Rosa26-LacZ mice, WT and E6/E7-expressing mice were treated at age 21 days with 3-mg dose of tamoxifen (30 mg/ml dissolved in corn oil; Sigma) administered by intraperitoneal injection. Mice were killed at the indicated times after tamoxifen treatment. To identify cells expressing b-galactosidase in back skins, we conducted LacZ staining as previously described. 49 Western blotting Whole-cell extracts were prepared from isolated keratinocytes as previously described. 55 After transfer, proteins were incubated with the antibodies anti-EGFP (1:1000; Abcam, Cambridge, UK), anti-K15 (1:100; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-P-cadherin (1:500; R&D Systems) and anti-b-actin (1:10.000; Sigma). Antibody binding was detected with a secondary antibody coupled to horseradish peroxidase using enhanced chemiluminescence.
Tumor-induction experiments
Back skin from E6/E7 mice (8-12-week-old) was shaved and then treated with DMBA and TPA as previously described. 56 Histology, immunofluorescence and immunohistochemistry Skins were fixed in 4% formaldehyde overnight at 4 1C, embedded in paraffin wax and sectioned at 4 mm. For immunofluorescence or immunohistochemical staining, antigen retrieval was performed in 10 mM sodium citrate (pH 6.0). Skin sections were blocked with 5% horse serum in phosphate-buffered saline for 1 h at room temperature and incubated with primary antibodies overnight at 4 1C. The primary antibodies used were anti-K15 (1:100; Santa Cruz), anti-EGFP (1:500; Abcam), anti-P-cadherin (1:500; R&D Systems), anti-K14 (1:400; Covance, Emeryville, CA, USA), anti-K5 (1:1000; Covance), anti-K10 (1:500; Covance), anti-Ki67 (1:100; Invitrogen) and anti-b-catenin (1:150; BD Bioscience). Skin sections were then incubated with secondary antibodies for 1 h at room temperature. The MOM Basic Kit (Vector Laboratories, Burlingame, CA, USA) was used for mouse monoclonal antibodies (following the manufacturer's instructions). To analyze CD34-expressing cells, tissue samples were embedded in optimal cutting temperature, and sections were incubated with biotin-labeled CD34 antibody (1:100; eBioscience) overnight at 4 1C. To visualize EGFP directly, skins were fixed in 4% formaldehyde for 30 min and then embedded in optimal cutting temperature. Nuclei were stained using 4 0 ,6-diamidino-2-phelylindole (DAPI) for immunofluorescence. Samples were imaged on a Leica DM6000B microscope and a Leica TCS SP5 confocal microscope (Leica, Mannheim, Germany).
Reverse transcription and quantitative PCR Total RNA was extracted using Trizol (Invitrogen) and then cleaned in RNeasy Mini Spin columns (Qiagen, Germantown, MD, USA). RNA samples were DNase-treated with Turbo DNA-free (Ambion, Austin, TX, USA). The High Capacity cDNA Reverse Transcription kit (Applied Biosystems, Foster City, CA, USA) was used for reverse transcription. Real-time PCR reactions were performed on an Applied Biosystems 7900HT System, using PCR Master Mix No AmpErase UNG (Applied Biosystems) and TaqMan Gene Expression Assays (Supplementary Table S2 ). For HPV16 E6 mRNA quantification, quantitative real-time PCR was performed on a LightCycler 480 II System using LightCycler 480 SYBR Green Mix (Roche, Mannheim, Germany) and primers previously described. 57 All data were normalized with respect to Gapdh and Hprt1 expression. Author contributions: Conception and design was provided by VdSD, SSS, DRA and PM. Collection and assembly of data was performed by VdSD, SSS, DRA, AVG, MU, RMP and GP. Data analysis and interpretation was done by VdSD, SSS, DRA, AVG, MU, RMP, GP, EGS, OC, FV, JMP, EB and PM. The manuscript was written by PM.
